Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
Willemijn J. Jansen(Maastricht University), Helmut Hildebrandt(Carl von Ossietzky Universität Oldenburg), Gaël Chételat(Inserm), Mark A. van Buchem(Seoul National University), Juan Fortea(Hospital de Sant Pau), Rik Ossenkoppele(Malmö University), Ann D. Cohen(University of Pittsburgh), Kaj Blennow(Sahlgrenska University Hospital), Anne M. Fagan(Washington University in St. Louis), Philip Scheltens(Amsterdam University Medical Centers), Pieter Jelle Visser(Karolinska Institutet), Betty M. Tijms(Amsterdam Neuroscience), Wiesje M. van der Flier(Amsterdam Neuroscience), Mark Forrest Gordon(Boehringer Ingelheim (United States)), Estrella Gómez‐Tortosa(Hospital Universitario Fundación Jiménez Díaz), Henryk Barthel(Leipzig University), Harald Hampel(Sorbonne Université), Stefan Förster(German Center for Neurodegenerative Diseases), Kristian Steen Frederiksen(University of Copenhagen), Sebastiaan Engelborghs(Vrije Universiteit Brussel), David J. Brooks(Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Lucrezia Hausner(Heidelberg University), Tomasz Gabryelewicz(Mossakowski Medical Research Institute, Polish Academy of Sciences), Bart N.M. van Berckel(Amsterdam Neuroscience), Ina S. Almdahl(Oslo University Hospital), Lutz Froelich(Heidelberg University), Giovanni B. Frisoni(University of Geneva), Dag Aarsland(King's College London), Frans R.J. Verhey(Maastricht University), Sanna‐Kaisa Herukka(University of Eastern Finland), Adam Fleisher(Banner Alzheimer’s Institute), Olymbia Gkatzima(Aristotle University of Thessaloniki), Tormod Fladby(University of Oslo), Alexander Drzezga(Forschungszentrum Jülich), Vincent Camus(Université de Tours), Inês Baldeiras(University of Coimbra), Yvonne Freund‐Levi(Karolinska Institutet), Nadia Foskett(Roche (United Kingdom)), Steven E. Arnold(Massachusetts General Hospital), Daniel Alcolea(Hospital de Sant Pau), Kristen Bibeau(Research Triangle Park Foundation), Kewei Chen(Good Samaritan Medical Center), Sabine Hellwig(University Medical Center Freiburg), Enrica Cavedo(Sorbonne Université), Kiran Dip Gill(Post Graduate Institute of Medical Education and Research), Timo Grimmer(TUM Klinikum), Dirk L. Knol(Amyloidosis Foundation), M Alexander(Christian Medical College & Hospital), Lisa Ford(Janssen (United States)), Pauline Aalten(Maastricht University)
Cited by 1,623
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k